β2-microglobulin gene mutations in human melanoma cells: Molecular characterization and implications for immune surveillance

Melanoma Research

Volumn 7, Issue SUPPL. 2, 1997, Pages

  Hicklin, Daniel J ^a   Dellaratta, Dawn V ^a   Kishore, Raj ^a   Liang, Bitao ^a   Kageshita, Toshiro ^a   Ferrone, Soldano ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

2 Microglobulin; HLA class I antigen; Melanoma; Mutations; TAP

Indexed keywords

BETA 2 MICROGLOBULIN; HLA ANTIGEN CLASS 1;

ARTICLE; CANCER IMMUNOLOGY; GENE LOCUS; GENE MUTATION; HUMAN; IMMUNOSURVEILLANCE; MELANOMA; POINT MUTATION; PRIORITY JOURNAL; BIOSYNTHESIS; EXON; GENETICS; IMMUNOLOGY; PHYSIOLOGY; REVIEW;

BETA 2-MICROGLOBULIN; EXONS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOLOGIC SURVEILLANCE; MELANOMA; POINT MUTATION;

EID: 0030771088     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Bjorkman PJ, Parham P. Structure, function, and diversity of class I major histocompatibility complex molecules. Anna Rev Biochem 1990; 59:253-288.
2. Townsend AR, Gotch FM, Davey J. Cytotoxic T cells recognize fragments of the influenza nucleoprotein. Cell 1985; 42:457-167.
3. Morrison LA, Lukacher AE, Braciale VL. et al. Differences in antigen presentation to MHC class I-and class II-restrietecl influenza virusspecific cytolytic T lymphocyte clones. J Exp Med 1986; 163:903-921.
4. Ferrone S, Marincola FM. Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Immunol Today 1995; 16:487-194.
5. Goodfellow PN, Jones FA, Van Heyningen V, el al. The β-microglobulin gene is on chromosome 15 and not in the HLA-A region. Nature 1975; 254:267-269.
6. 2-microglobulin gene. Primary structure and definition of the transcriptional unit. J Immunol 1987; 139:3132-3138.
7. Germain RN. MHC-dependent antigen processing and pepticle presentation: providing ligands for T lymphocyte activation. Cell 1994; 76:287-299.
8. Powis SH, Trowsdale J. Human major histocompatibility complex genes. Behring Inst Mitt 1994; 94:17-25.
9. 2-microglobulin and peptide. J Exp Med 1992; 175:1653-1661.
10. Sadasivan B, Lehner PJ, Ortmann B, et al. Roles for calreticulin and a novel glycoprotein. tapasin, in the interaction of MHC class I molecules with TAP. Immunity 1996; 5:103-114.
11. 2-microglobulin, class I heavy chain conformation, and tapasin in the interactions of class I heavy chain with calreticulin and the transporter associated with antigen processing. J Immunol 1997; 158:2236-2241.
12. Suh WK, Mitchell FK, Yang Y, et al. MHC class I molecules form ternary complexes with calnexin and TAP and undergo peptide-regulated interaction with TAP via their extracellular domains. J Exp Med 1996: 184:337-348.
13. Deverson EV, Gow IR, Coadwell WJ, et al. MHC class II region encoding proteins related to the multidrug resistance family of transmembrane transporters. Nature 1990; 348:738-741.
14. Monaco JJ, Cho S, Attaya M. Transport protein genes in the murine MHC: possible implications for antigen processing. Science 1990; 250:1723-1726.
15. Trowsdale J, Hanson I, Mockridge I, et al. Sequences encoded in the class II region of the MHC related to the 'ABC' superfamily of transporters. Nature 1990; 348:741-744.
16. Spies T, Bresnahan M, Buhram S. el al. A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway. Nature 1990; 348:744-747.
17. Bahrain S, Arnold D, Bresnahan M, et al. Two putative subunits of a peptide pump encoded in the human major histocompatibility complex class II region. Proc Natl Acad Sci U S A 1991; 88:10094-10098.
18. Michalek MT, Grant KP. Gramm C, el al. A role for the ubiquitindependent proteolytic pathway in MHC class I-restricted antigen presentation. Nature 1993: 363:552-554.
19. Belich MP, Trowsdale J. Proteasome and class I antigen processing and presentation. Mol Biol Rep 1995; 21:53-56.
20. Coux O, Tanaka K, Goldberg AL. Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem 1996; 65:801-847.
21. 2 M gene expression. J Clin Invest 1991; 7:284-292.
22. 2-microglobulin messenger RNA. J Clin Invest 1993; 91:684-692.
23. 2 -microglobulin gene. Hum Immunol 1996; 47:26.
24. 2-Microglobulin gene is mutated in a human colon cancer cell line (HCT) deficient in the expression of HLA class I antigens on the cell surface. Cancer Res 1992; 52:1201-1204.
25. 2-Microglobulin gene mutations: a study of established colorectal cell lines and fresh tumors. Proc Natl Acad Sci U S A 1994; 91:4751-1756.
26. Chen HL, Gabrilovich D, Virmani A, et al. Structural and functional analysis of beta 2 microglobulin abnormalities in human lung and breast cancer. Int J Cancer 1996; 67:756-763.
27. Fishel R, Lescoe MK, Rao MR, et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1994; 77:167-169.
28. Parsons R, Li GM, Longley MJ,et al. Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell 1993; 75:1227-1236.
29. Aquilina G, Hess P, Branch P, et al. A mismatch recognition defect in colon carcinoma confers DNA microsatellite instability and a mutator phenotype. Proc Natl Acad Sci U S A 1994; 91:8905-8909.
30. Shibata D, Navicli W, Salovaara R, et al. Somatic microsatellite mutations as molecular tumor clocks. Nat Med 1996; 2:676-681.
31. Loeb LA, Christians EC. Multiple mutations in human cancers. Mutat Res 1996; 350:279-286.
32. Branch P Bicknell DC, Rowan A, et al. Immune surveillance in colorectal carcinoma. Nat Genet 1995; 9:231-232.
33. 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy. J Natl Cancer Inst 1996; 88:100-108.
34. Ruiter DJ, Bergman W, Welvaart K, et al. Immunohislochemical analysis of malignant melanomas and nevocellular nevi with monoclonal antibodies to distinct monomorphic determinants of HLA antigens. Cancer Res 1984; 44:3930-3935.
35. 2-Microglobulin expression in normal melanocytes, nevocellular nevi, and malignant melanoma. J lnvst Dermatol 1989; 92:243S-247S.
36. Brown MG. Driscoll J, Monaco JJ. Structural and serological similarity of MHC-linked LMP and proteasome (multicatalytic proteinase) complexes. Nature 1991; 353:355-357.
37. Glynne R, Powis SH, Beck S, el al. A proteasome-related gene between the two ABC transporter loci in the class II region of the human MHC. Nature 1991; 353:357-360.
38. Martinez CK, Monaco JJ. Homology of proteasome suhunits to a major histocompatibility complex-linked LMP gene. Nature 1991; 353:664-667.
39. Kelly A, Powis SU, Glynne R, et al. Second proteasome-related gene in the human MHC class II region. Nature 1991; 353:667-668.
40. Rivoltini L, Barracchini KC, Viggiano V, el al. Quantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytes. Cancer Kes 1995; 55:3149-3157.
41. 2 M gene. J Clin Invest 1991; 88:282-289.
42. 2microglobulin nRNA in human Daudi cells has a mutated initiation codon but is still inducble by Interferon. EMHO J 1983; 2:239-243.
43. Hicklin DJ, Kageshita T, Dellaratta DV, et al. Defects in HLA class 1 antigen presentation machinery in melanoma cells. In Immunology of Human Melanoma. Tumor-Host Interaction and Immunothcrapy. Edited by Maio M. Amsterdam: IOS Press, 1996:95-111.
44. Pellegrino MA, Ng A-K, Russo C, et al. Heterogeneous distribution of the determinants defined by monoclonal antibodies on HLA-A and B antigens bearing molecules. Transplantation 1982; 34:18-23.
45. Stain NJ, Spits H, Ploegh HL Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. J Immunol 1986; 137:2299-306.
46. Barnstable, CJ., Bodmer WF, Brown G, et al. Production of monoclonal antibodies to group A erythrocytes, HLA and the human cell surface antigens: new tools for genetic analysis. Cell 1978; 14:9-20.
47. Hicklin DJ. Kageshita T, Ferrone S. Development and characterization of rabbit antisera to human MHC-linked transporters associated with antigen processing. Tissue Antigens 1996; 48:38-46.